Identifying early signs of behavior issues in at-risk infants
Characterizing early signs of neurobehavioral dysregulation in infants at increased risk for behavioral disorders
This study is looking at how to spot early signs of behavior challenges in babies who might be at risk, especially those exposed to nicotine before birth, so we can help them get the right support as they grow.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11052927 on NIH RePORTER |
What this research studies
This research focuses on understanding the early signs of neurobehavioral dysregulation in infants who are at increased risk for behavioral disorders, particularly those exposed to prenatal nicotine. By examining various developmental factors such as attention, motor skills, and sleep patterns, the study aims to identify infants who may be more likely to develop persistent behavioral issues like ADHD. The approach involves using advanced methodologies to categorize these infants into distinct risk groups, which could lead to more tailored interventions. The research will utilize multiple constructs to assess behavior and development over time.
Who could benefit from this research
Good fit: Ideal candidates for this research include infants under 1 year of age who have been exposed to prenatal nicotine or exhibit early signs of behavioral dysregulation.
Not a fit: Patients who are older than 3 years or do not have any identified risk factors for behavioral disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier identification and intervention for infants at risk of developing behavioral disorders, potentially improving long-term outcomes.
How similar studies have performed: Previous research has shown promise in identifying early behavioral markers in at-risk populations, suggesting that this approach could yield valuable insights.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Maylott, Sarah E. — Duke University
- Study coordinator: Maylott, Sarah E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.